Table 5.
Study | Number of patients (n) | Sensitivity (%) | Specificity (%) | Disease prevalence (%) |
---|---|---|---|---|
Lewin et al. [17] | 26 | 100 | 86.7 | 50 |
Dromain et al. [2] | 144 | 93 | 63 | 56.3 |
Dromain et al. [18] | 110 | 91.9 | 46 | 56.7 |
Fallenberg et al. [19] | 80 | 100 | - | 100 |
Jochelson et al. [3] | 52 | 96 | - | 100 |
Fallenberg et al. [8]a | 118 | 94.7*/95** | - | 100 |
Lobbes et al. [5] | 113 | 100 | 87.7 | 28 |
Luczyńska et al. [4] | 152 | 100 | 41 | 76 |
Cheung et al. [20] | 89 | 92.7 | 67.9 | 72 |
Luczyńska et al. [22] | 118 | 100 | Not provided | 68.6 |
Cheung et al. [21]b | 52 | 90.9 | 83.78 | 37.7 |
Disease prevalence based on number of lesions analysed in the included population is given, calculated from data given in study
Annotations: aSensitivity for CESM alone (*) and for CESM in combination with mammography (**). bPatients with microcalcifications only